Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Guangdong Provincial People's Hospital
Tempus AI
The First Affiliated Hospital of Soochow University
AstraZeneca
Centre hospitalier de l'Université de Montréal (CHUM)
M.D. Anderson Cancer Center
Geneplus-Beijing Co. Ltd.
Sun Yat-sen University
Insight Molecular Diagnostics
Bristol-Myers Squibb
Hospices Civils de Lyon
Radiation Therapy Oncology Group
University of Wisconsin, Madison
Samsung Medical Center